Abstract

Epilepsy is one of the most common serious brain conditions, affecting over 70 million people worldwide. Its incidence has a bimodal distribution with the highest risk in infants and older age groups. Progress in genomic technology is exposing the complex genetic architecture of the common types of epilepsy, and is driving a paradigm shift. Epilepsy is a symptom complex with multiple risk factors and a strong genetic predisposition rather than a condition with a single expression and cause. These advances have resulted in the new classification of epileptic seizures and epilepsies. A detailed clinical history and a reliable eyewitness account of a seizure are the cornerstones of the diagnosis. Ancillary investigations can help to determine cause and prognosis. Advances in brain imaging are helping to identify the structural and functional causes and consequences of the epilepsies. Comorbidities are increasingly recognised as important aetiological and prognostic markers. Antiseizure medication might suppress seizures in up to two-thirds of all individuals but do not alter long-term prognosis. Epilepsy surgery is the most effective way to achieve long-term seizure freedom in selected individuals with drug-resistant focal epilepsy, but it is probably not used enough. With improved understanding of the gradual development of epilepsy, epigenetic determinants, and pharmacogenomics comes the hope for better, disease-modifying, or even curative, pharmacological and non-pharmacological treatment strategies. Other developments are clinical implementation of seizure detection devices and new neuromodulation techniques, including responsive neural stimulation.

Keywords

EpilepsyMedicinePharmacogenomicsNeuromodulationDeep brain stimulationDiseaseEpileptogenesisEpilepsy syndromesIntensive care medicineEtiologyGenetic predispositionNeuroscienceBioinformaticsPsychiatryPsychologyPathologyInternal medicineStimulationParkinson's diseaseBiologyPharmacology

MeSH Terms

AdultAnticonvulsantsEpilepsyHumansSeizures

Affiliated Institutions

Related Publications

Publication Info

Year
2019
Type
review
Volume
393
Issue
10172
Pages
689-701
Citations
1876
Access
Closed

Social Impact

Altmetric
PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1876
OpenAlex
37
Influential
1741
CrossRef

Cite This

Roland D. Thijs, Rainer Surges, Terence J. O’Brien et al. (2019). Epilepsy in adults. The Lancet , 393 (10172) , 689-701. https://doi.org/10.1016/s0140-6736(18)32596-0

Identifiers

DOI
10.1016/s0140-6736(18)32596-0
PMID
30686584

Data Quality

Data completeness: 81%